Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-29 01:09:39 - browse：827

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today, we explore the future of obesity drugs and how they’re named, we chat with CRISPR pioneers about what it’s like to see the technology approved for human use, and more.

The need-to-know this morning:
• Bayer said it prematurely stopped a Phase 3 study in stroke prevention after independent monitors concluded its experimental blood-thinning medicine, called asundexian, showed inferior efficacy compared to a standard treatment. The asundexian study setback is a significant blow to Bayer’s effort to revamp its drug-development pipeline, analysts said.
• Carmot Therapeutics filed paperwork Friday for an initial public offering of undisclosed size. The Berkeley, Calif.-based company is developing drugs that target GLP-1 and GIP to treat diabetes and obesity, similar to Novo Nordisk’s Ozempic/Wegovy and Eli Lilly’s Mounjaro/Zepbound.
• Bristol Myers Squibb and 2Seventy Bio said the FDA will not complete an on-time review of its application seeking to expand the use of Abecma, their CAR-T therapy for multiple myeloma. Instead, the FDA will convene an advisory panel meeting — date to be determined — to examine survival data from an Abecma clinical trial.
• The U.K. and the pharmaceutical industry have reached a deal on a five-year plan outlining how the health system pays for drugs, as the country tries to keep a lid on its medicines spending while simultaneously building up its life sciences industry. STAT’s Andrew Joseph has more here.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Woodcock on FDA’s accelerated approval and her next chapter

focus

WSS

International team creates first chimeric human

Medical device lobby: We're tired of waiting on Medicare coverage

An inside look at PIPEs, biotech's buzzy new financing tool

Scientists unlock the key to scar

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

What we need to know about Arena Bioworks

leisure time

Wikipedia

explore

Medical records are filled with copy

ARCH Venture Partners is raising $3 billion for a life sciences fund

Duchenne breakthrough therapy leaves behind pioneering families

RaDonda Vaught to speak at CommonSpirit event on patient safety

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Jerome Adams on the need for new antivirals for Covid

In search for therapies for solid tumors, companies turn to claudin

Peter Hotez and the public health issue of online harassment

Time to name cancers by genetics, not organ of origin, expert says

focus

Covid misinformation case heads to Supreme Court

Vertex non

Congress gives doctors Medicare pay bump

Why getting cancer drugs just got harder for rural patients

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

A $475,000 price tag for a new cancer drug: crazy or meh?

knowledge

entertainment

focus

Wikipedia